US-based Argon Medical Devices has launched the TRAVELER Portal Vein Access Series, which serves as the latest addition to the company’s portal vein access product portfolio.

TRAVELER has been designed to improve the visualisation and durability of components, helping to address some of the common challenges faced during Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures.

The new product line aids physicians in accessing the portal vein through the liver during these procedures.

Now available in Canada and the US, the new TRAVELER Series includes TRAVELER16, TRAVELER21 and TRAVELER38.

Argon Medical Devices president and CEO George Leondis said: “Our mission is to improve the lives of patients and caregivers through the innovation, manufacturing, and delivery of best-in-class medical devices.

“Thus, we were compelled to act when we identified an opportunity to simplify complex portal vein access procedures for our customers.

“We are excited to launch our new TRAVELER products for this purpose and see the positive impact they have on portal access procedures and outcomes in accordance with our mission.”

The company stated that the launch of the TRAVELER series is the first of multiple new product launches planned for this year.

It also noted that the new Portal Vein Access Series supplements its Scorpion Series, which was launched in 2021 and also supports TIPS procedures.

Including the Scorpion and ScorpionX products, the Scorpion Series provides improved navigation control, visualisation and durability for current procedural methods.

It uses a patented curve-in-curve system to provide a 360-degree range of motion for the needle or stylet that is used to access the portal vein.